Growth Metrics

Vivos (RDGL) Preferred Shares Repurchased (2020)

Vivos recorded quarterly Preferred Shares Repurchased of $13650.0 in Q4 2020, down 72.7% quarter-over-quarter from $50000.0 in Q1 2020.

Vivos' Preferred Shares Repurchased history runs 1 years deep, the most recent figure standing at $13650.0 for Q4 2020.

  • In Q4 2020, Preferred Shares Repurchased changed N/A year-over-year to $13650.0; the TTM figure through Dec 2020 stood at $63650.0 (changed N/A YoY), while the FY2020 annual figure was $63650.0, changed N/A from the prior year.
  • Preferred Shares Repurchased came in at $13650.0 for Q4 2020 at Vivos, down from $50000.0 in the prior quarter.
  • In the past five years, Preferred Shares Repurchased ranged from a high of $50000.0 in Q1 2020 to a low of $13650.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares Repurchased (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Vivos - - -3,105.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 13,650.00
Dec 31, 2020 13,650.00
Mar 31, 2020 50,000.00
Mar 31, 2020 50,000.00